Azenta, Inc. (AZTA) Stock Price & Analysis
Azenta, Inc. (AZTA) fell 3.29% to USD 27.37 as of July 25, 2026 at 15:42 UTC, according to Nexqual real-time market data.
AZTA last closed at USD 28.3; the session ranged USD 27.32–28.29 on volume of 663,465 shares. Market capitalization is $1.26B, with a 52-week range of USD 15.93–41.73 (NMS). Source: Nexqual, July 25, 2026 at 15:42 UTC.
Key Statistics (as of July 25, 2026 at 15:42 UTC)
| Price | USD 27.37 |
|---|---|
| Change | ▼ 3.29% (down) |
| Previous Close | USD 28.3 |
| Open | USD 28.29 |
| Day Range | USD 27.32 – 28.29 |
| 52-Week Range | USD 15.93 – 41.73 |
| Volume | 663,465 shares |
| Market Cap | $1.26B |
| Exchange | NMS |
Technical Analysis (AZTA)
Nexqual's technical model rates AZTA "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 15:42 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.13 (neutral) |
| vs SMA50 | Above (USD 23.3) |
| MACD | 1.04 (positive) |
Analyst Ratings (AZTA)
Wall Street analysts rate AZTA "Buy" based on 5 analysts, with a mean price target of USD 27.8 (range USD 20–33), per Nexqual as of July 25, 2026 at 15:42 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 27.8 |
| High Target | USD 33 |
| Low Target | USD 20 |
| Buy / Hold / Sell | 3 / 3 / 0 |
Earnings (AZTA)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.1 |
| Revenue Estimate | $149.23M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.04 vs est 0.14 ▼ miss |
| 2025-12-31 | USD 0.09 vs est 0.13 ▼ miss |
| 2025-09-30 | USD 0.21 vs est 0.2 ▲ beat |
| 2025-06-30 | USD 0.19 vs est 0.14 ▲ beat |
Source: Nexqual, July 25, 2026 at 15:42 UTC.
Financials & Fundamentals (AZTA)
| Total Revenue | $596.48M |
|---|---|
| Revenue Growth (YoY) | +1.00% |
| Gross Margin | +44.33% |
| Operating Margin | -10.56% |
| Profit Margin | -29.06% |
| ROE | -6.81% |
| Debt / Equity | 3.58 |
| Current Ratio | 2.83 |
| Total Cash | $380.52M |
| Total Debt | $55.71M |
| Free Cash Flow | $101.33M |
Source: Nexqual, July 25, 2026 at 15:42 UTC.
Financial Health Score (AZTA)
Nexqual rates Azenta, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 15:42 UTC.
| Growth | Weak — Revenue -10% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 44%, operating -11% |
| Balance Sheet | Strong — $381M cash vs $56M debt, net cash position |
| Cash Flow | Strong — FCF $101M, 17% margin |
| Efficiency | Critical — ROE -7%, ROA -0.6% |
Ownership (AZTA)
| Insider Ownership | +1.00% |
|---|---|
| Institutional Ownership | +110.42% |
| Shares Outstanding | 46.09M |
| Float | 40.60M |
| Short % of Float | +20.61% |
Source: Nexqual, July 25, 2026 at 15:42 UTC.
Leadership (AZTA)
Azenta, Inc. is led by John P. Marotta (age 44), President, CEO & Director, per Nexqual as of July 25, 2026 at 15:42 UTC.
| President, CEO & Director | John P. Marotta (age 44) |
|---|---|
| Executive VP & CFO | Lawrence Y. Lin (age 48) |
| Vice President of Financial Planning & Analysis and Investor Relations | Yvonne Perron |
| Senior Vice President & President of Multiomics | William E. Martin (age 50) |
| Vice President and General Manager of Sample Repository Solutions | Alex Esmon |
Major Backers & Investors (AZTA)
Notable institutional backers of Azenta, Inc. include Politan Capital Management LP, Conestoga Capital Advisors, LLC, Conestoga Funds-Conestoga Small Cap Fund, according to Nexqual as of July 25, 2026 at 15:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Politan Capital Management LP | 10.03% |
| Conestoga Capital Advisors, LLC | 6.17% |
| Conestoga Funds-Conestoga Small Cap Fund | 4.01% |
| Massachusetts Financial Services Co. | 3.88% |
| Allspring Global Investments Holdings, LLC | 3.5% |
| American Capital Management, Inc. | 2.81% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 22.11% |
| Vanguard Group | 16.64% |
| Dimensional Fund Advisors | 4.47% |
| State Street | 3.82% |
Source: Nexqual, July 25, 2026 at 15:42 UTC.
From Azenta, Inc.'s Latest SEC 10-K Filing (filed 2025-12-04)
Key Strengths & Strategy (as disclosed to the SEC)
- Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
- It operates through Sample Management Solutions and Multiomics segments.
- The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
- This segment also offers consultation services to clients throughout their experimental design and implementation processes.
Partnerships
- The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHC | Sotera Health Company | USD 17.35 | ▲ 0.35% |
| STVN | Stevanato Group S.p.A. | USD 19.68 | ▲ 1.6% |
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| ENOV | Enovis Corporation | USD 27.03 | ▲ 1.81% |
| NVST | Envista Holdings Corporation | USD 26.33 | ▼ 0.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:42 UTC. This page is informational and not investment advice.